Boyle Secures $20 million for Lung Cancer Research in FY21
PHILADELPHIA, PA – Congressman Brendan F. Boyle (PA-02), co-chair of the Congressional Lung Cancer Caucus, successfully secured $20 million for Lung Cancer Research in Fiscal Year 2021 by leading a letter with 41 Members of Congress to prioritize this funding. This is an increase of $14 million from the previous year.
“This significant increase in research funding will help save lives and help medical experts better understand this deadly disease,” said Congressman Boyle. “Lung cancer is the leading cause of cancer deaths in the United States, particularly for veterans and young women, and yet, it is the least funded in terms of research dollars per death. As co-chair of the Congressional Lung Cancer Caucus, I will continue to make sure federal research for lung cancer is robustly funded so that we can improve preventative care, early diagnosis, and treatment.”
The Lung Cancer Research Program (LCRP) within the Defense Appropriation’s Congressionally Directed Medical Research Program (CDMRP) had been funded below its original $20 million allocation since Fiscal Year 2009, which has limited life-saving investments in research. The full letter can be read here.